113 results
Page 3 of 6
8-K
EX-99.1
8c1p rn3qvm
10 Nov 21
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:16pm
8-K
EX-1.1
fix 3npo9l3bafmwhc
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
rrnwktcepho5nditj3a
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K/A
lzog dvib
16 Jun 21
Submission of Matters to a Vote of Security Holders
6:05am
8-K
EX-99.1
zc5tqo7
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
5furyuq0
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
8-K
0lzcdxa04 gq4u0
11 Dec 20
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
8:31am
8-K
EX-99.1
455y5vf
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K
EX-99.1
8zx1acjt zu
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm
8-K
EX-1.1
po6cmth
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
4zxvnro
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
78ne9q
23 Jun 20
Prospectus supplement for primary offering
4:06pm